Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

No reported Total Equity figures are available to summarize.

Total Equity history

Currency unavailable · from the balance sheet

No Total Equity data reported for this period type.

Total Equity vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Total Equity for LTGO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PCRXPacira BioSciences, Inc.Mar 2026$653.89M USD-18.1%-3.7%54.1%
COLLCollegium Pharmaceutical, Inc.Mar 2026$312.42M USD+33.3%+15.7%18.9%
SCLXScilex Holding CompanyMar 2026-$254.07M USD-20.1%—86.5%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —-18.1%+6.0%54.1%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.